Health Innovations Pharmacy Recalls DHEA Capsules Due to Sterility Concerns
Health Innovations Pharmacy is recalling DHEA 10 mg SR Capsules because inspection findings indicate a lack of assurance regarding sterility and stability data.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations, injuries, or illnesses. The hazard is based on inspection observations regarding quality control and sterility assurance rather than confirmed adverse health events, fitting the criteria for a moderate severity score.
Plain-English summary
Health Innovations Pharmacy, Inc. is recalling DHEA 10 mg SR Capsules. The recall was initiated following recent inspection observations associated with certain quality control procedures. These observations present a risk to the sterility and quality assurance of the product, as the available data does not support the stated expiry dates.
The recall covers all lots of the product. The distribution pattern is listed as North Carolina (NC). The source text does not specify the exact number of units affected or the specific dates of distribution.
Consumers who have purchased these capsules should stop using them and contact Health Innovations Pharmacy at (910) 246-5155 for further instructions or a refund.
The recalled product
- Product
- DHEA 10 mg SR Caps, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
- Manufacturer
- Health Innovations Pharmacy, Inc
- Category
- Drug — Pharmaceutical
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 65 recalled by Health Innovations Pharmacy, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 65 products in this recall →Related recalls
Same manufacturer · Health Innovations Pharmacy, Inc
See all →- ModerateCarvedilol 1.25 mg/mL Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighProgest Cream Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighHealth Innovations Pharmacy Recalls Phospholine Iodide Eye Drops
FDA (Drugs) · 2015-05-20
- HighNortriptyline Suspension Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighHealth Innovations Pharmacy Recalls Naltrexone Capsules Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighInjectable NADH Recalled for Sterility Concerns at Manufacturing Facility
FDA (Drugs) · 2023-02-01
- HighInjectable Vitamin D3 Products Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-01
- HighInjectable Hydroxocobalamin Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighEdetate Calcium Disodium Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01
- SevereNatures Pharmacy Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- HighPharmacy Innovations Apomorphine Injectable Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-02-01